AUGUST’S TOP TRADE IDEA

Market Strategist: The Best Long-Term Idea Is 'Just Buy Nvidia And Put It Away'

Before it’s late-August earnings call, NVIDIA Corp. (NVDA) had beaten revenue estimates in seven straight quarters and nine of the last 10 quarters. The company had also beaten earnings per share estimates in six straight quarters and eight of the last 10 quarters.

And while the other “Magnificent Seven” tech stocks had faltered, NVIDIA was still going strong. No wonder, then, that Freedom Capital Markets Chief Global Strategist Jay Woods emphasized the importance of NVIDIA's earnings report on the market during an interview on Benzinga's "PreMarket Prep."

Here’s why he thought the best idea was just to buy the stock, no matter what.

PRESENTED BY MONOGRAM ORTHOPEDICS

Monogram Orthopedics (NASDAQ: MGRM) Lands Key Clinical Trial Partnership With India’s Leading Orthopedic Hospital Group To Advance Its Surgical Robot Tech

AI-powered robotics company Monogram Technologies (Nasdaq: MGRM) has secured a key partnership with Shalby Limited (NSE: SHALBY), India’s leading orthopedic hospital group, to advance its surgical robot technology. Through a multicenter clinical trial campaign, Shalby will select patients across India as candidates for Monogram’s mBȏs TKA System with the Consensus CKS implant, the closest equivalent to the Monogram mPress implants for regulatory purposes. India represents massive market potential for robotic orthopedic surgery and implants, as evidenced by over 200,000 total knee arthroplasties (TKAs) completed annually. Upon regulatory approval, Monogram will perform its first live inpatient OUS surgeries alongside Shalby. Investors who are interested in the investment opportunity in  cutting-edge robotics technology in a market with only a few autonomous players can learn more about Monogram Orthopedics and its surgical robot here.

AUGUST’S TOP MARKET STORY

Norwegian Cruise Line Sails Into Troubled Waters As Financial Struggles, Bearish Trends Persist

Norwegian Cruise Line Holdings Ltd. (NCLH) has faced rough seas this year, with its stock down 13.02% year-to-date, a 6.32% decline over the past year, and a sharp 19.23% drop in just the past month.

The company's financial outlook is under pressure, and with significant industry headwinds on the horizon, investors are left questioning whether the worst is still to come.

And now, the storied cruise line is facing something even worse.

Here’s what’s signaling even more trouble for the stock’s future.

PRESENTED BY THERIVA BIOLOGICS

Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers

Many types of cancer are considerably more survivable today than they were 40 years ago. Still, many forms of cancer are as difficult to treat today as they were in the 1980s. Theriva Biologics™ is working to address this through its oncolytic virus therapies.

In a recent interview, the principal investigator and country coordinator of Theriva’s main clinical site in Spain, Dr. Garcia-Carbonero, noted that metastatic PDAC – a type of pancreatic cancer – has a high fatality rate despite recent treatment advancements.

While the field has seen minimal improvement in standard care for decades, she said that in speaking of one of Theriva’s lead candidates she has “high hopes for VCN-01 due to its unique mechanism of action, which differs from traditional chemotherapy. VCN-01 aims to induce a robust immune response against the cancer.”

To learn more about the science behind their work, click here.

CRAMER’S BIG MISTAKE

'I'm Not Proud Of Myself': Jim Cramer Says He Bought 'Worst Of The Three' GE Stocks

In early August, Jim Cramer of “Mad Money” made a startling admission.

GE HealthCare Technologies Inc. (GEHC) had just reported a “decent” quarter, Cramer said, and had been hurt by China.

Then came the bomb: “I bought the worst of the three, and I'm not proud of myself.”

Here’s what he meant - and what other winners and losers he called for in this “Mad Money Lightning Round…”

PRESENTED BY GLUCOTRACK

Continuous Blood Glucose Monitoring Can Materially Improve The Quality Of Life For People With Diabetes – Glucotrack Wants To Make It Easier

Managing diabetes isn’t easy. From watching what you eat to multiple finger pricks a day, keeping blood sugar at bay can be cumbersome and intrusive. But it doesn’t have to be. Continuous glucose monitoring devices (CGM) promise to make managing diabetes a whole lot easier.

Glucotrack, Inc. (NASDAQ: GCTK) is one company trailblazing in that area. The Rutherford, New Jersey medical technology company focused on the design, development and commercialization of novel technologies for people with diabetes, developed a CBGM that aims to overcome the challenges of today’s CGMs including interstitial glucose lag, the need for frequent calibration and concerns regarding comfort and wearability.

Glucotrack’s implantable CBGM measures glucose in the blood without the lag time associated with subcutaneous sensors that measure glucose in interstitial fluid. The company says users get real-time readings with its device. What’s more, Glucotrack’s implant can last up to three years, compared to less than one year for many of the rival devices on the market.

To learn more about Glucotrack’s CGM, click here.

AUGUST’S TOP POLICY STORY

Researchers Identify 'Trump Dump' Effect: Ex-President Is Already Causing Deep Stock Losses In Companies And Industries He Targets

In August the stock market experienced a significant downturn, which researchers attribute to the actions and statements of former President Donald Trump. The phenomenon dubbed as the “Trump Dump” effect, has been linked to the former president’s public criticisms of specific companies and sectors.

Here are the stocks that Trump targeted, and the ones he may hit again…

PRESENTED BY PASOFINO GOLD

Pasofino Gold: Unlocking Liberia’s Untapped Gold Potential

Pasofino Gold is poised to unlock Liberia's untapped gold potential through its Dugbe Gold Project, covering over 2,000 square kilometers in a region rich with gold deposits. Despite exploring less than 20% of the area, the company has already identified promising resources, including 3.3 million ounces of gold in the Dugbe F and Tuzon areas. With Liberia's pro-mining stance and a strong partnership with the local community, Pasofino Gold is positioned to significantly impact the gold market. Explore this investment opportunity today by visiting Pasofino Gold's website.

AUGUST’S TOP TECH STORY

Google Says Opening Up Its App Store Is Expensive And Too Much Work, Gets Told By Judge, 'We're Going To Tear The Barriers Down'

Following a federal jury’s unanimous ruling eight months ago that Google’s Android store is an illegal monopoly in the Epic v. Google case, the judge in the case made his intentions clear during the final hearing on remedies.

While Google argued that opening its store to rival stores would be too much work or cost too much, Judge Donato has dismissed these claims. “We’re going to tear the barriers down, it’s just the way it’s going to happen,” he stated.

Here’s what that could mean for the tech giant…

PRESENTED BY SIGMA LITHIUM

Sigma Lithium Boosts Productions Cuts Costs In Q2

Sigma Lithium Corp.’s (NASDAQ: SGML) recently reported second-quarter earnings that demonstrated the company’s ability to grow its business, with it posting an increase in the volume of lithium sold. But that’s not all. The global lithium producer dedicated to powering the next generation of electric vehicles was able to cut costs ahead of schedule for the three months that ended in June.

On top of that, Sigma Lithium also expects production in the third quarter to hit around 60,000 tons, up from the second quarter. “Operationally, the company has invested in improving the throughput and recovery at our Greentech plant, which will bear fruit in the third quarter further increasing the efficiency of the operations,” said Ana Cabral, Co-Chairperson and CEO of Sigma Lithium, in an earnings release.

The company is also diversifying its customer base, adding new customers to its roaster during the quarter. To learn more about Sigma Lithium’s quarterly results and its prospects click here.

AUGUST’S TOP ELECTION STORY

Trump Vs. Harris: Polling Veteran Nate Silver Says Vice President Has 97% Chance Of Winning Electoral College if She Secures This Pivotal State

Although Vice President Kamala Harris has built up a small lead over her rival and Republican candidate Donald Trump, the situation is still fluid. Against the backdrop, veteran pollster Nate Silver delved into the prospects of both candidates in two of the key swing states.

The pollster identified one state in particular as crucial for Harris to win the election…

PRESENTED BY PERCENT

Explore the Benefits of Private Credit Investing

If you study the capital flows and announcements of the world’s largest asset managers, you’ll notice that private credit has become one of the hottest asset classes of 2024.

With Percent, accredited investors like you can participate in this booming asset class and tap attributes like:

• High yield potential (up to 20% APY) plus cash flow from monthly interest payments

• The option to redeploy capital frequently with shorter-term investments

• A wide swath of deals, ranging from small business loans, merchant cash advances, trade finance, consumer loans, and more across the US, Canada, and Latin America

With the market at all-time highs, many investors turn to private credit because its returns are historically less correlated to public markets, which can stabilize a portfolio during a downturn.

Start Your Private Credit journey and grab a $500 bonus on your first investment.